Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Medical Developments International Limited ( (AU:MVP) ) has provided an update.
Medical Developments International Limited has announced its 2025 Annual General Meeting, scheduled for October 10, 2025, at 1 pm AEDT. The meeting will be conducted in a hybrid format, allowing both in-person and virtual attendance via the Computershare platform. Shareholders are encouraged to submit proxy forms as per the instructions provided. This approach reflects the company’s commitment to accessibility and engagement with its stakeholders, potentially impacting shareholder participation and company transparency.
The most recent analyst rating on (AU:MVP) stock is a Buy with a A$0.80 price target. To see the full list of analyst forecasts on Medical Developments International Limited stock, see the AU:MVP Stock Forecast page.
More about Medical Developments International Limited
Medical Developments International Limited operates in the healthcare industry, focusing on the development and distribution of medical products. The company is known for its innovative solutions in pain management and respiratory care, catering to both domestic and international markets.
Average Trading Volume: 146,825
Technical Sentiment Signal: Sell
Current Market Cap: A$64.78M
For a thorough assessment of MVP stock, go to TipRanks’ Stock Analysis page.